In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation: The ROTATE multicentre registry

Hiroyoshi Kawamoto, Azeem Latib, Neil Ruparelia, Alfonso Ielasi, Fabrizio D'Ascenzo, Mauro Pennacchi, Gennaro Sardella, Roberto Garbo, Emanuele Meliga, Claudio Moretti, Marco Luciano Rossi, Patrizia Presbitero, Caroline J. Magri, Sunao Nakamura, Antonio Colombo, Giacomo G. Boccuzzi, Emanuele Barbato

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Aims: The aim of this multicentre study was to investigate the in-hospital and midterm outcomes of rotational atherectomy (RA) followed by metallic stent implantation. Methods and results: Between 2002 and 2013, 1,176 de novo lesions with calcified coronary lesions treated by RA and metallic stent implantation at nine institutions were assessed. Patients with ST-segment elevation myocardial infarction (STEMI) within 30 days, cardiogenic shock before the procedure, lesions with thrombus, and in-stent restenosis were excluded from the current analysis. In-hospital major adverse cardiac events (MACE) occurred in 8.3% of cases, mainly driven by periprocedural myocardial infarction. The incidence of MACE was 16.0% at one-year and 24.9% at two-year follow-up, both driven by target vessel revascularisation (13.5% at one year and 19.8% at two years). Multivariable analysis revealed that dialysis was an independent predictor for both in-hospital MACE (OR 2.33, 95% CI: 1.11-4.87, p=0.03) and follow-up MACE (HR 4.14, 95% CI: 2.87-5.96, p<0.001), whilst drug-eluting stent (DES) use was associated with a reduction in follow-up MACE (HR 0.42, 95% CI: 0.26-0.67, p<0.001). Conclusions: RA appears to be safe and effective with acceptable in-hospital and follow-up MACE considering the severity of patient and lesion characteristics. DES implantation following RA was associated with a reduction in MACE during the follow-up period.

Original languageEnglish
Pages (from-to)1448-1456
Number of pages9
JournalEuroIntervention
Volume12
Issue number12
DOIs
Publication statusPublished - Dec 1 2016

Fingerprint

Coronary Atherectomy
Stents
Registries
Drug-Eluting Stents
Cardiogenic Shock
Multicenter Studies
Dialysis
Thrombosis
Myocardial Infarction
Incidence

Keywords

  • Atherectomy
  • Calcified lesions
  • Coronary
  • Drug-eluting stents
  • Intervention
  • Percutaneous
  • Rotational

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Kawamoto, H., Latib, A., Ruparelia, N., Ielasi, A., D'Ascenzo, F., Pennacchi, M., ... Barbato, E. (2016). In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation: The ROTATE multicentre registry. EuroIntervention, 12(12), 1448-1456. https://doi.org/10.4244/EIJ-D-16-00386

In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation : The ROTATE multicentre registry. / Kawamoto, Hiroyoshi; Latib, Azeem; Ruparelia, Neil; Ielasi, Alfonso; D'Ascenzo, Fabrizio; Pennacchi, Mauro; Sardella, Gennaro; Garbo, Roberto; Meliga, Emanuele; Moretti, Claudio; Rossi, Marco Luciano; Presbitero, Patrizia; Magri, Caroline J.; Nakamura, Sunao; Colombo, Antonio; Boccuzzi, Giacomo G.; Barbato, Emanuele.

In: EuroIntervention, Vol. 12, No. 12, 01.12.2016, p. 1448-1456.

Research output: Contribution to journalArticle

Kawamoto, H, Latib, A, Ruparelia, N, Ielasi, A, D'Ascenzo, F, Pennacchi, M, Sardella, G, Garbo, R, Meliga, E, Moretti, C, Rossi, ML, Presbitero, P, Magri, CJ, Nakamura, S, Colombo, A, Boccuzzi, GG & Barbato, E 2016, 'In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation: The ROTATE multicentre registry', EuroIntervention, vol. 12, no. 12, pp. 1448-1456. https://doi.org/10.4244/EIJ-D-16-00386
Kawamoto, Hiroyoshi ; Latib, Azeem ; Ruparelia, Neil ; Ielasi, Alfonso ; D'Ascenzo, Fabrizio ; Pennacchi, Mauro ; Sardella, Gennaro ; Garbo, Roberto ; Meliga, Emanuele ; Moretti, Claudio ; Rossi, Marco Luciano ; Presbitero, Patrizia ; Magri, Caroline J. ; Nakamura, Sunao ; Colombo, Antonio ; Boccuzzi, Giacomo G. ; Barbato, Emanuele. / In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation : The ROTATE multicentre registry. In: EuroIntervention. 2016 ; Vol. 12, No. 12. pp. 1448-1456.
@article{241eb7230b734fc68fcf0081d9bd6d75,
title = "In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation: The ROTATE multicentre registry",
abstract = "Aims: The aim of this multicentre study was to investigate the in-hospital and midterm outcomes of rotational atherectomy (RA) followed by metallic stent implantation. Methods and results: Between 2002 and 2013, 1,176 de novo lesions with calcified coronary lesions treated by RA and metallic stent implantation at nine institutions were assessed. Patients with ST-segment elevation myocardial infarction (STEMI) within 30 days, cardiogenic shock before the procedure, lesions with thrombus, and in-stent restenosis were excluded from the current analysis. In-hospital major adverse cardiac events (MACE) occurred in 8.3{\%} of cases, mainly driven by periprocedural myocardial infarction. The incidence of MACE was 16.0{\%} at one-year and 24.9{\%} at two-year follow-up, both driven by target vessel revascularisation (13.5{\%} at one year and 19.8{\%} at two years). Multivariable analysis revealed that dialysis was an independent predictor for both in-hospital MACE (OR 2.33, 95{\%} CI: 1.11-4.87, p=0.03) and follow-up MACE (HR 4.14, 95{\%} CI: 2.87-5.96, p<0.001), whilst drug-eluting stent (DES) use was associated with a reduction in follow-up MACE (HR 0.42, 95{\%} CI: 0.26-0.67, p<0.001). Conclusions: RA appears to be safe and effective with acceptable in-hospital and follow-up MACE considering the severity of patient and lesion characteristics. DES implantation following RA was associated with a reduction in MACE during the follow-up period.",
keywords = "Atherectomy, Calcified lesions, Coronary, Drug-eluting stents, Intervention, Percutaneous, Rotational",
author = "Hiroyoshi Kawamoto and Azeem Latib and Neil Ruparelia and Alfonso Ielasi and Fabrizio D'Ascenzo and Mauro Pennacchi and Gennaro Sardella and Roberto Garbo and Emanuele Meliga and Claudio Moretti and Rossi, {Marco Luciano} and Patrizia Presbitero and Magri, {Caroline J.} and Sunao Nakamura and Antonio Colombo and Boccuzzi, {Giacomo G.} and Emanuele Barbato",
year = "2016",
month = "12",
day = "1",
doi = "10.4244/EIJ-D-16-00386",
language = "English",
volume = "12",
pages = "1448--1456",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "EuroPCR",
number = "12",

}

TY - JOUR

T1 - In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation

T2 - The ROTATE multicentre registry

AU - Kawamoto, Hiroyoshi

AU - Latib, Azeem

AU - Ruparelia, Neil

AU - Ielasi, Alfonso

AU - D'Ascenzo, Fabrizio

AU - Pennacchi, Mauro

AU - Sardella, Gennaro

AU - Garbo, Roberto

AU - Meliga, Emanuele

AU - Moretti, Claudio

AU - Rossi, Marco Luciano

AU - Presbitero, Patrizia

AU - Magri, Caroline J.

AU - Nakamura, Sunao

AU - Colombo, Antonio

AU - Boccuzzi, Giacomo G.

AU - Barbato, Emanuele

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Aims: The aim of this multicentre study was to investigate the in-hospital and midterm outcomes of rotational atherectomy (RA) followed by metallic stent implantation. Methods and results: Between 2002 and 2013, 1,176 de novo lesions with calcified coronary lesions treated by RA and metallic stent implantation at nine institutions were assessed. Patients with ST-segment elevation myocardial infarction (STEMI) within 30 days, cardiogenic shock before the procedure, lesions with thrombus, and in-stent restenosis were excluded from the current analysis. In-hospital major adverse cardiac events (MACE) occurred in 8.3% of cases, mainly driven by periprocedural myocardial infarction. The incidence of MACE was 16.0% at one-year and 24.9% at two-year follow-up, both driven by target vessel revascularisation (13.5% at one year and 19.8% at two years). Multivariable analysis revealed that dialysis was an independent predictor for both in-hospital MACE (OR 2.33, 95% CI: 1.11-4.87, p=0.03) and follow-up MACE (HR 4.14, 95% CI: 2.87-5.96, p<0.001), whilst drug-eluting stent (DES) use was associated with a reduction in follow-up MACE (HR 0.42, 95% CI: 0.26-0.67, p<0.001). Conclusions: RA appears to be safe and effective with acceptable in-hospital and follow-up MACE considering the severity of patient and lesion characteristics. DES implantation following RA was associated with a reduction in MACE during the follow-up period.

AB - Aims: The aim of this multicentre study was to investigate the in-hospital and midterm outcomes of rotational atherectomy (RA) followed by metallic stent implantation. Methods and results: Between 2002 and 2013, 1,176 de novo lesions with calcified coronary lesions treated by RA and metallic stent implantation at nine institutions were assessed. Patients with ST-segment elevation myocardial infarction (STEMI) within 30 days, cardiogenic shock before the procedure, lesions with thrombus, and in-stent restenosis were excluded from the current analysis. In-hospital major adverse cardiac events (MACE) occurred in 8.3% of cases, mainly driven by periprocedural myocardial infarction. The incidence of MACE was 16.0% at one-year and 24.9% at two-year follow-up, both driven by target vessel revascularisation (13.5% at one year and 19.8% at two years). Multivariable analysis revealed that dialysis was an independent predictor for both in-hospital MACE (OR 2.33, 95% CI: 1.11-4.87, p=0.03) and follow-up MACE (HR 4.14, 95% CI: 2.87-5.96, p<0.001), whilst drug-eluting stent (DES) use was associated with a reduction in follow-up MACE (HR 0.42, 95% CI: 0.26-0.67, p<0.001). Conclusions: RA appears to be safe and effective with acceptable in-hospital and follow-up MACE considering the severity of patient and lesion characteristics. DES implantation following RA was associated with a reduction in MACE during the follow-up period.

KW - Atherectomy

KW - Calcified lesions

KW - Coronary

KW - Drug-eluting stents

KW - Intervention

KW - Percutaneous

KW - Rotational

UR - http://www.scopus.com/inward/record.url?scp=85006958573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006958573&partnerID=8YFLogxK

U2 - 10.4244/EIJ-D-16-00386

DO - 10.4244/EIJ-D-16-00386

M3 - Article

AN - SCOPUS:85006958573

VL - 12

SP - 1448

EP - 1456

JO - EuroIntervention

JF - EuroIntervention

SN - 1774-024X

IS - 12

ER -